DTM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DT Midstream is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is in a constructive uptrend and analyst sentiment has improved, but the current price is already near the top of the recent trading range and the short-term technical setup is not an obvious low-risk entry. Since you are unwilling to wait for an ideal pullback, my direct view is to hold off and wait rather than buy at this level.
DTM is trading at 149.22 with price above the pivot at 147.271 and below resistance at 150.709. The moving averages are bullish, with SMA_5 > SMA_20 > SMA_200, which supports the ongoing uptrend. MACD histogram is positive at 0.243, though it is contracting, suggesting momentum is still positive but easing. RSI_6 at 68.374 is elevated and close to overbought territory, which limits near-term upside. Overall, the trend is bullish, but the stock is already extended enough that this is not an ideal immediate entry for a beginner long-term buyer.
["Analyst price targets have risen across several firms, with UBS, Citi, Jefferies, and Morgan Stanley all lifting targets materially.", "UBS kept a Buy rating and highlighted two new projects benefiting from power demand.", "Jefferies noted a slight Q1 beat and positive signaling on MIST commercialization and possible expansion projects.", "Raymond James said the stock still merits a premium due to its contracted footprint and growing project backlog.", "Bullish technical structure remains intact with SMA_5 > SMA_20 > SMA_200 and positive MACD."]
["The stock is near short-term resistance at 150.709, limiting immediate upside.", "RSI is elevated at 68.374, suggesting the stock is somewhat stretched.", "No news in the recent week means no fresh catalyst to drive an immediate breakout.", "SwingMax shows no recent signal and AI Stock Picker shows no signal today.", "Predicted near-term stock trend is weak, with modeled downside over the next week and month.", "Hedge funds and insiders are both neutral, showing no notable accumulation trend."]
No latest-quarter financial snapshot was provided because the data returned an error, so I cannot reliably assess revenue, EBITDA, EPS, or margin growth for the latest quarter season. Based on analyst commentary, Q1 appears to have been slightly better than expected, and management/news flow around project sanctions and backlog conversion has been viewed positively, but the actual financial metrics were not supplied.
Analyst sentiment has improved noticeably over the last few weeks. Several firms raised price targets: UBS to $170 with a Buy, Citi to $169 with a Buy, Jefferies to $166 with a Buy, Morgan Stanley to $170 with an Equal Weight, Raymond James to $158 with Outperform, and Mizuho to $153 with Neutral. The bullish case from pros centers on contracted assets, project backlog, power demand, and expansion optionality. The bearish case is mainly valuation and execution risk, reflected by Goldman Sachs keeping a Sell despite raising its target. Overall Wall Street sentiment is moderately positive, but not unanimous.
